Beta Bionics

Overview

Beta Bionics is a medical technology company founded in Massachusetts in 2015. It is dedicated to improving the lives of people with diabetes through innovative automated insulin delivery systems. Co-founded by Ed Damiano, a biomedical engineering professor, the company aims to simplify diabetes management by focusing on the real needs of the diabetes community.

The company's flagship product, the iLet Bionic Pancreas, automates insulin delivery by using continuous glucose monitoring data to make dosing decisions without manual calculations. The system mimics the natural function of the pancreas and can deliver glucagon when necessary. The Color iLet features a color screen and enhanced alerts for improved usability. Beta Bionics prioritizes clinical research and user-centered design to create technology that meets the needs of individuals with type 1 diabetes.

Basic Information

Contact Details

• Phone: +1 855-745-3800
• Website: betabionics.com
• LinkedIn: linkedin.com/company/beta-bionics

Key Focus Areas & Initiatives

• The iLet Bionic Pancreas
• Medical/dental instruments
• Health care
• Glucose monitoring integration
• Automated insulin and glucagon delivery
• Diabetes technology innovation
• Clinical trials
• Patient monitoring app
• Digital health services
• Glucagon delivery technology
• Real-world data collection
• Automated insulin adjustment
• Insulin pump solutions
• FDA medical device development
• Diabetes data analytics
• Digital health platform
• Closed-loop insulin system
• Insulin management software
• Personalized insulin therapy
• Cloud connectivity for diabetes devices
• Sensor integration
• Remote patient monitoring
• Diabetes care technology
• User-centered and patient-centered design

Technologies Used

• Amazon SES
• Apache
• Atlassian Cloud
• Google Tag Manager
• Greenhouse.io
• Mobile Friendly
• Outlook
• Remote
• Salesforce
• Typekit
• WordPress.org

Affiliated Organizations & Regional Branches